PsyPost on MSN
Cannabidiol shows no significant benefit for treating psychotic disorders, new study finds
Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...
AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...
A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution ...
Ananda Pharma Limited is a UK based bio pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions.
A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of ...
Increased puff capacity provides greater value compared to lesser puff count devicesNew, AWARD-WINNING FLAVORS provide maximum satisfaction to adult consumersCOSTA MESA, CA, July 06, 2026 (GLOBE ...
A clear look at 10 health conditions Canadians manage with medical cannabis, the real evidence behind each one, and how eligibility actually works in Canada.
HLB Life Science R&D, the research and development subsidiary of HLB, a prominent Korean life sciences conglomerate, has been ...
Trait Biosciences highlights CBD82S™ reducing anxiety-like behavior in mice, showcasing enhanced absorption via ...
The Drug Enforcement Administration is considering a proposal to move marijuana from Schedule I to Schedule III of the ...
A recent study is raising new questions about whether cannabis-derived compounds could one day play a role in liver care.
A study published in the Journal of Cannabis Research assessed the safety and tolerability of cannabidiol (CBD) and alcohol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results